CHD4 deficiency was shown to reduce the recruitment of homologous recombination repair factor BRCA1, and it impaired the efficiency of homologous recombination repair, which could affect the treatment of breast cancer characterized by BRCA1/BRCA2 mutations (Abdelmohsen et al., 2012). The gene discussed is BRCA1; the disease is breast carcinoma.